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By inactivating the gene for L-gulono-g-lactone oxidase, a key
enzyme in ascorbic acid synthesis, we have generated mice that,
like humans, depend on dietary vitamin C. Regular chow, contain-
ing about 110 mgykg of vitamin C, is unable to support the growth
of the mutant mice, which require L-ascorbic acid supplemented in
their drinking water (330 mgyliter). Upon withdrawal of supple-
mentation, plasma and tissue ascorbic acid levels decreased to
10–15% of normal within 2 weeks, and after 5 weeks the mutants
became anemic, began to lose weight, and die. Plasma total
antioxidative capacities were approximately 37% normal in ho-
mozygotes after feeding the unsupplemented diet for 3–5 weeks.
As plasma ascorbic acid decreased, small, but significant, increases
in total cholesterol and decreases in high density lipoprotein
cholesterol were observed. The most striking effects of the mar-
ginal dietary vitamin C were alterations in the wall of aorta,
evidenced by the disruption of elastic laminae, smooth muscle cell
proliferation, and focal endothelial desquamation of the luminal
surface. Thus, marginal vitamin C deficiency affects the vascular
integrity of mice unable to synthesize ascorbic acid, with poten-
tially profound effects on the pathogenesis of vascular diseases.
Breeding the vitamin C-dependent mice with mice carrying defined
genetic mutations will provide numerous opportunities for sys-
tematic studies of the role of antioxidants in health and disease.
Oxygen-derived free radicals are inevitable byproducts ofnormal biological functions such as respiration, energy
generation, biosynthesis of macromolecules, and protection
against infections. Normally, free radicals are swiftly destroyed
by various antioxidant enzymes and small antioxidant molecules,
which the body produces to prevent free radicals from reacting
with lipids, proteins, and nucleic acids. Failure to maintain a
coordinated balance between the production of free radicals and
defenses against them can lead to cell death, tissue injury, and
disease. Thus, much attention has been given in recent years to
oxidative stress as a potentially important factor in the patho-
genesis of many diseases, including atherosclerosis, cancer, and
neurodegenerative diseases (1–4).
Studies of the pathogenesis of human diseases have benefited
from the availability of small laboratory animal models for many
years. Mutant mice are particularly useful for investigating the
interplay of genetic and environmental factors in the pathogen-
esis of common, but multifactorial, diseases (5). However, there
is a major handicap for studies involving the endogenous redox
systems of humans and mice: humans (and other primates) lack
the ability to synthesize ascorbic acid because of a loss of
function in the gene (Gulo) coding for a key synthetic enzyme,
L-gulono-g-lactone oxidase (6), whereas mice have the func-
tional gene. As a consequence, mouse tissues generally have high
levels of ascorbic acid, which are only slightly influenced by
exogenous vitamin C. In contrast, humans depend entirely on
vitamin C derived from the diet. Guinea pigs also have lost this
enzyme function and depend on dietary vitamin C (7). Hence
severe deficiency of vitamin C causes disease (scurvy) in both
primates and guinea pigs. A strain of rats (ODS, Osteogenic
Disorder Sionogi, ref. 8) also has a defect in the same gene (9).
No mouse strain is known with this deficiency, yet such mice, in
which vitamin C intake can be controlled by diet, would be
particularly valuable for investigating the interplay between
endogenous and exogenous redox systems, genetic factors, and
various diseases. To this end, we have generated Gulo 2y2
mutant mice, and we here describe the effects of vitamin C
deficiency on three factors influential in vascular disease: plasma
antioxidative capacity, plasma lipoprotein levels, and vascular
integrity.
Materials and Methods
Gene Targeting. Using published sequences of the rat Gulo gene
(7), we isolated a phage clone spanning exons 3–7 of the mouse
Gulo gene (Fig. 1A). The targeting construct (Fig. 1B) was
designed to modify the locus so that a neomycin resistance gene
replaces exons 3 and 4. A 6-kb EcoRI fragment containing exons
5–7 provided a 39 arm of homology, and a 1.4-kb EcoRIyBamHI
fragment in intron 2 formed a 59 arm of homology. The neomycin
resistance gene (pMC1neo) and the Herpes simplex thymidine
kinase gene (pGKTK) both are oriented oppositely from the
transcriptional orientation of the Gulo gene in the construct.
Mouse embryonic stem cells were cultured as described (10).
The PCR primers used for screening homologous recombinants
were P1 (59-AATTGACCCGAGTCCTGGCT-39) and P2 (59-
CGCGCCTTAATTAAGGATCC-39), located 59 to the EcoRI
site in the Gulo intron 2 and within the linker of the vector.
Clones that generated a 1.5-kb PCR fragment were expanded
and confirmed by Southern blot analyses with two EcoRIySacI
fragments of 0.3 kb and 0.8 kb from introns 2 and 7, respectively,
as probes.
Mice. Chimeras were generated as described (10) and mated with
C57BLy6 mice. For genotyping by PCR, three primers, P2
described above, P3 (59-GTCGTGACAGAATGTCTTGC-39),
and P4 (59-GCATCCCAGTGACTAAGGAT-39) were used
with tail DNA in a single reaction. A 230-bp fragment derived
with P2 and P3 from the targeted locus andyor a 330-bp fragment
derived with P3 and P4 from the endogenous locus distinguish
homozygous, heterozygous, and wild-type animals.
Animals were handled as approved by the Institutional Ani-
mal Care and Use Committee. Mice were weaned at 3 weeks of
age and fed ad libitum with irradiated mouse chow (PicoLab
5058, PMI Feeds, St. Louis). They had free access to water with
or without vitamin C. The average ascorbic acid content of the
diet was 110 mgykg. To supplement vitamin C, drinking water
was made to contain 330 mg L-ascorbic acidyliter and 0.01 mM
EDTA and changed at least once a week. Heterozygous or
homozygous mutant breeding pairs were kept on vitamin C
supplementation for the production of homozygous pups, which
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were weaned onto vitamin C-supplemented water unless specif-
ically stated. Heterozygotes were maintained on regular chow
without ascorbic acid supplementation, unless specifically stated.
All mice used in the current experiments were younger than
6 months old and had a mixed genetic background derived from
the strains 129 and C57BLy6. Blood was obtained either from
the retroorbital sinus or by heart puncture and was anticoagu-
lated with heparin or EDTA. Mice were euthanized with an
overdose of Avertin (2,2,2-tribromoethanol) followed by fixation
of the vasculature with 4% paraformaldehyde through the left
ventricle at a physiological pressure.
Biochemical Measurements. Ascorbic acid levels were measured by
the a,a9-dipyridyl method as described (11). Antioxidative ca-
pacities of fresh plasma were determined by an enhanced
chemiluminescence assay, based on the potential to quench light
emission from a glowing horseradish peroxidase-catalyzed en-
hanced chemiluminescence reaction (12). The antioxidant ac-
tivity was expressed by comparison with the quenching activity
of a tocopherol-analogue, trolox. Lipid peroxidation was assayed
colorimetrically as free malonaldehyde plus 4-hydroxyalkenals
by using a kit (Oxis International, Portland, OR) according to
the supplier’s protocol. Plasma levels of cholesterol and triglyc-
erides were determined enzymatically with kits obtained from
Wako BioProducts (Richmond, VA) and Sigma. High density
lipoprotein (HDL) cholesterol levels were determined after
removing apolipoprotein B-containing particles by magnesiumy
dextran precipitation method (13). Fractionation of the plasma
lipoproteins by ultracentrifugation and SDS gel electrophoresis
of apolipoproteins have been described (14). Hematological
determinations were made with an Animal Blood Counter (ABC
vet, ABX Hematology, Garden Grove CA).
Liver RNA was isolated by using the TRI reagent (Molecular
Research Center, Cincinnati). Northern blot analyses were done
by conventional methods, using a 450-bp Gulo-cDNA probe
generated by reverse transcription–PCR of the mRNA isolated
from wild-type liver and primer sequences corresponding to
exons 3 and 7. The probe for the glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) gene, pTRI-GAPDH-mouse, was
obtained from Ambion (Austin TX).
The significance of differences between means was calculated
by ANOVA (JMP software, SAS, Cary, NC).
Microscopic Examination. For transmission electron microscopy
(TEM), two 0.3-cm sections of the thoracic aorta just distal to the
left common carotid artery were processed by using standard
protocols and embedded in Epon resin. One-micrometer thick
sections were cut, stained with toluidine blue, and examined by
light microscopy. Sections with detectable abnormalities were
thin-sectioned, stained with uranyl acetate followed by lead
citrate, and viewed by using a Phillips 301 TEM at 60 kV.
For scanning electron microscopy, the entire aortic arch from
the heart to just proximal to the left common carotid was
dehydrated through a graded series of ethanol solutions, treated
with hexamethyldisilazane, and allowed to air-dry overnight. The
samples were bisected, placed on nickel stubs, coated with a thin
layer of carbon and a mixture of goldypalladium, and viewed by
using a Leo (Helsingborg, Sweden) model 435VP scanning
electron microscope at 20 kV.
To assay vascular permeability, Evans blue (30 mgykg) was
injected into animals through the tail vein 15 min before the
sacrifice (15). The ascending aorta was removed and frozen in
OCT compound, and cross sections (6 mm) were prepared.
Extravasation of macromolecules was evaluated under fluores-
cent microscopy (Nikon B2A) with an excitation filter at 400–
440 nm, a dichromic mirror at 510 nm, and a barrier filter at 520
nm.
Results
Inactivation of the Murine Gulo Gene. The strategy for inactivating
the Gulo gene is shown in Fig. 1. A missense mutation in the Gulo
gene of Osteogenic Disorder Sionogi rats that replaces cysteine
at position 61 in exon 3 with tyrosine is sufficient to dramatically
reduce mRNA stability and enzyme activity (9), and the Gulo
gene in guinea pigs has a stop codon at codon 61 in exon 3 in
addition to many other defects in exon 6 (7). There therefore can
be little doubt that deletion of the sequences containing exons
3 and 4 eliminates all gene function. Even if splicing were to
occur between exons 2 and 5, the reading frame is not preserved.
On Southern blot analyses, DNA from the modified cells gave a
14-kb SacI fragment and a 9.5-kb HindIII fragment hybridizing
to probe a in addition to 5.5-kb SacI and 8-kb HindIII endog-
enous fragments; probe b hybridized to a 14-kb SacI fragment in
addition to the endogenous 9-kb fragment (not shown). Two
chimeras generated from targeted cells transmitted the embry-
onic stem cell genome to their F1 pups.
Gulo-Deficient Mice Depend on Dietary Vitamin C. When heterozy-
gous F1 animals were mated, homozygous pups (2y2) were born
at the expected frequency. The homozygous mice lack Gulo gene
expression as shown in the Northern blot hybridization of total
RNA isolated from the liver (Fig. 1D). The body weights of
homozygous pups born to heterozygous mothers were not dif-
ferent at 21 days of age from their heterozygous and wild-type
litter mates. However, after weaning onto regular chow, which
contains about 110 mgykg of ascorbic acid, the homozygotes
grew very little, and after 40 days of age they began to lose
weight, whereas the body weights of wild types and heterozygotes
steadily increased (Fig. 2A). In this experiment, one of the three
homozygotes died on the 47th day, but after supplementation of
vitamin C in the drinking water at 330 mgyliter the remaining
two began to gain weight. This amount of vitamin C supple-
Fig. 1. Targeted modification of the mouse Gulo gene. (A) The endogenous
mouse Gulo locus. The thick horizontal bar indicates the phage clone con-
taining exons 3–7, marked by black boxes. (B) The targeting vector. Arrows P1
and P2 are relative positions of primers used to screen embryonic stem cells for
the targeting event. (C) The inactivated Gulo locus. [a] and [b] are probes used
for Southern blottings. Sizes and restriction enzymes of fragments diagnostic
for the modification are indicated. B, BamHI; Bg, BglII; E, EcoRI; H, HindIII; N,
NotI; S, SacI; X, XbaI. (D) Northern blot analysis of the liver RNA (20 mg) isolated
from the livers of a male and a female of the three Gulo genotypes. The filter
was hybridized with a Gulo probe (Upper), washed, and rehybridized with a
glyceraldehyde-3-phosphate dehydrogenase gene (Gapdh) probe (Lower).
The positions of 28S and 18S RNA are marked.
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mentation, also used in Osteogenic Disorder Sionogi rats (16),
allows homozygous animals to gain weight and reproduce nor-
mally, as long as they remain on vitamin C supplementation.
In mature mice, withdrawal of vitamin C for longer than 5
weeks causes weight loss (Fig. 2B) and death. By the sixth week
the animals had lost an average 30% of their body weight and
become anemic as evidenced by a significant reduction in their
red blood cell counts (238%), hemoglobin concentration
(237%), and hematocrit (235%). At necropsy, hemorrhages
often were detected in knee joints and the dorsal margin of the
scapula. Some animals had petechia in the intestinal mucosa.
External bleeding was not seen in the mutant mice. All major
organs were histologically unremarkable, and the immediate
cause of death was not apparent.
Thus we found that approximately 0.08 mgyg of body weighty
day (with supplementation) of ascorbic acid is sufficient for
normal health in the Gulo 2y2 mice, assuming that an average
mouse weighs 25 g and eats 4 g of chowyday and drinks 4.5 ml
of wateryday (17). However, 0.02 mgyg of body weightyday (on
chow diet only) cannot sustain normal body function.
Gulo 2y2 Homozygotes Have Reduced Tissue and Plasma Ascorbic
Acid Levels and a Reduction in Plasma Antioxidant Capacity. Ascorbic
acid levels in the plasma, liver, and brain of the Gulo 2y2
homozygous mutants maintained on unsupplemented chow for
3–5 weeks are 1.7 6 0.2 mgyml, 31 6 2 mgyg, and 112 6 14 mgyg,
respectively (Fig. 3 A–C). These values are significantly lower
(P , 0.001) than those in wild type (11.1 6 0.5 mgyml, 186 6 8
mgyg, and 511 6 15 mgyg, respectively). The levels in heterozy-
gotes are also slightly lower than normal, although the difference
is not statistically significant except in the plasma (9.6 6 0.3
mgyml, P , 0.03). Supplementation with 330 mgyliter of vitamin
C in water normalizes the plasma levels in heterozygotes and
increases the levels in homozygotes to approximately 60%
normal. The plasma levels in supplemented homozygous males
(5.7 6 0.3 mgyml, n 5 6) are significantly lower than the levels
in females (8.2 6 0.5 mgyml, n 5 6, P , 0.001), and a similar
trend is also present in heterozygotes (10.8 6 0.7 vs. 12.4 6 0.5,
n 5 6, not significant). Plasma ascorbic acid levels do not differ
between male and female wild-type mice.
In parallel to the reduced ascorbic acid levels, the plasma
antioxidative capacities in the homozygous mutants (48 6 7 mM
trolox equivalent, P , 0.001) are significantly lower than those
in wild-type mice (134 6 41 mM) and heterozygous mice (112 6
31 mM). The antioxidative capacities in heterozygotes are also
lower than wild-type mice, although this difference is not
statistically significant (Fig. 3D). Comparison between plasma
vitamin C levels and antioxidative capacity in individual animals
demonstrates a significant positive correlation between ascorbic
acid levels and plasma antioxidative capacity (r2 5 0.69, P ,
0.0001, Fig. 3E). The intercept (37 mM) of the regression line
suggests that antioxidants other than ascorbic acid explain 28%
of the total antioxidative capacities (134 mM) in the normal
mouse plasma.
The levels of lipid peroxidation products measured as free
malonaldehyde plus 4-hydroxyalkenals in liver homogenates
(80 6 41 nmolyg of tissue, n 5 10) of homozygotes were not
statistically different from those in wild-type mice (71 6 19
nmolyg of tissue, n 5 19). The lipid peroxidation in plasma was
below detection in both wild type and homozygotes by this
method. Thus, despite a reduction in plasma antioxidative
capacities, the Gulo 2y2 mice do not accumulate lipid peroxides
in tissues.
Plasma Ascorbic Acid Levels Correlate Negatively with Plasma Total
Cholesterol and Positively with HDL-Cholesterol Levels. Because
animal and epidemiological studies have suggested an associa-
tion between plasma lipid levels and ascorbic acid levels, we
tested whether reduced plasma and tissue ascorbic acid levels are
correlated with the plasma lipid and lipoprotein distribution in
our mice. We found a significantly increased mean plasma
cholesterol levels in males (Fig. 4A) and a trend toward it in
females (Fig. 4B) with a decrease in the number of the functional
Gulo genes. Both Gulo genotype and gender of animals signif-
icantly affected the plasma cholesterol levels in mice with the
Gulo genotype explaining 7% of the variance (P , 0.01) and
Fig. 2. Body weight changes of Gulo 2y2 mice. (A) Females from a single
litter from a heterozygous pair weaned on regular chow at age 21 days. Mean
weights 6 SD of one wild type plus three heterozygotes (F) and of three
homozygotes (E) are shown. At day 45, vitamin C (330 mgyliter) in the drinking
water was given to the animals (stippled circle). Because one homozygote died
at day 47, the values at days 51 and 54 are the average weights of two
homozygotes. Differences between two groups were statistically significant
at all time points. (B) Nine Gulo 2y2 males were raised on chow with vitamin
C supplementation to 8 weeks of age and then supplementation was with-
drawn from six of the mice. Mean body weights 6 SD for three mice with
vitamin C supplementation (stippled square) and for six mice without supple-
mentation (h) are shown, except that the 14th week was for three mice. P ,
0.01 at 13-week time point. Fig. 3. Ascorbic acid (AA) levels in plasma (A), liver (B), and brain (C).
Homozygous (2y2) mice were on chow diet without vitamin C supplement for
3–5 weeks. Data are expressed mean 6 SE. P , 0.0001. (D) Plasma total
antioxidative capacity expressed as trolox equivalent (mM). P , 0.0001. (E)
Correlation between plasma ascorbic acid and total antioxidative capacity of
individual animals including all three genotypes.











gender explaining 8% (P , 0.005). Significant effects on HDL
cholesterol levels in 80 animals also were observed as a function
of genotype (P , 0.05) and gender (P , 0.02), with each
explaining 8% of the variance.
Regression analyses of values using individual animals, in-
cluding all genotypes and with or without supplement, in which
both data are available, revealed that plasma levels of ascorbic
acid are negatively correlated with total cholesterol levels, but
positively with HDL cholesterol levels. The correlations were
highly significant with plasma ascorbic acid levels explaining
about 10% of the variance in total cholesterol (P , 0.001, Fig.
4C), and 8% of the variance in HDL cholesterol (P , 0.05, Fig.
4D).
Plasma lipoproteins fractionated by ultracentrifugation
showed that the cholesterol in low density lipoprotein fraction of
homozygotes was higher than in wild type (24% vs. 16% when
averaged from two experiments using plasma pooled from at
least five each group of mice). HDL fraction in homozygotes was
decreased compared with wild type (75% vs. 80%). There were
no remarkable differences in apolipoprotein composition in
these fractions (not shown). Plasma triglyceride levels are not
different among the three genotypes.
Taken together, these data demonstrate that a suboptimal
ascorbic acid has a small, but significant, effect on the plasma
cholesterol levels and suggests that it increases the levels of
atherogenic lipoprotein particles. However, these effects are
small, and the Gulo 2y2 mice are not overtly hypercholester-
olemic.
Rupture of Elastic Lamina, Smooth Muscle Cell Proliferation, and
Injury of the Luminal Surface in the Thoracic Aorta. Ascorbic acid is
an important cofactor for the hydroxylation of proline and lysine
necessary for the crosslinking of collagen and elastin, important
structural components of vessel wall (18, 19). Inspection under
both light microscopy and TEM of cross sections of the thoracic
aorta from animals with low levels of plasma and tissue ascorbic
acid revealed marked alterations in the pattern and integrity of
the elastic laminae. Prominent breaks and fragmentation of the
elastica were located in both the superficial and deep media (Fig.
5B). The endothelial cells overlying the areas of internal elastic
lamia disruption were attenuated as a result of the accumulation
Fig. 4. Plasma cholesterol levels in the Gulo mutant males (A) and females
(B). Mean 6 SEM. Homozygotes (2y2) were on chow with vitamin C supple-
ment until 3–5 weeks before the determinations. Heterozygotes and wild-
type mice were on unsupplemented chow at all times. Correlation between
plasma ascorbic acid (AA) and plasma total cholesterol (C) and HDL choles-
terol (D) levels in individual animals including all three genotypes. Some
homozygotes were with vitamin C supplement and others were unsupple-
mented. E, females; ■, males.
Fig. 5. Abnormalities in the aorta of Gulo 2y2 mice. (A) A cross section of the descending thoracic aorta from a wild-type mouse showing uninterrupted elastic
laminae. Toluidine blue staining, light microscopy, 3400. (B) A cross section of the descending thoracic aorta from a Gulo 2y2 mouse with disrupted elastic
laminae. Light microscopy, 3400. (C) TEM of the area adjacent to that shown in B. A single layer of mildly activated smooth muscle cells (smc) is present in the
intima between endothelial cells (ec) and superficial elastic lamina (sel). A break in the elastica is marked by an arrow. Magnification: 34,000. (D) Scanning
electron microscopy of the aortic arch of a wild-type mouse showing a normal luminal surface. lca, left carotid artery; rca, right carotid artery. Magnification:
320. (E) Scanning electron microscopy of the aortic arch of an Gulo 2y2 mouse showing multiple longitudinal surface defects (arrows). Magnification: 320. (F)
Higher magnification (3200) of the defect.
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of basement membrane material, collagenyelastic tissue, and
aggregates of smooth muscle cells. Some smooth muscle cells
had an altered morphology, were devoid of cytoplasmic fila-
ments, and contained myelin figures indicative of cellular de-
generation (not shown). Small clusters of smooth muscle cells,
ranging from a few to a diffuse collections of several cells, were
present within the subintima below the basement membrane and
above the superficial elastic lamina (Fig. 5C). Most of the smooth
muscle cells present within the intima were mildly activated as
judged by a slight increase in their rough endoplasmic reticulum.
Small collections of elastic fibers were located between smooth
muscle cells both in the intima and in the deep media, suggesting
that reorganization of the elastic lamina is a dynamic process in
these mice.
On scanning microscopy, the aortic arches from the vitamin
C-deficient mice contained focal areas where the normal endo-
thelial cell pattern was absent (Fig. 5E). The foci with loss of
normal endothelial architecture were oriented in the direction of
blood flow and most often were located in the aortic wall near
the takeoff of the carotid arteries. The surface was rough and
irregular but devoid of fibrin deposition and attached blood cells,
with the exception of occasional red blood cells (Fig. 5F).
Cytoplasmic extensions of adjacent endothelial cells were in
contact with the edges of the defects, and remnants of endo-
thelial cells were present within the altered areas. Although
aortic segments from all 10 Gulo 2y2 mice evaluated had at
least one of such lesions, sections of the aortic arch in none of
the wild-type mice showed abnormalities in the arrangements
and integrity of the endothelial cells (Fig. 5D).
To determine the effects of these lesions on vascular perme-
ability, wild-type and Gulo 2y2 mice were injected with Evans
blue dye before sacrifice. On examination of frozen sections
using fluorescence microscopy, the ascending thoracic as well as
abdominal aortas from vitamin C-deficient mice showed patchy
areas of dye binding to the elastica (Fig. 6B), indicating that there
were changes in endothelial permeability that allowed leakage of
macro-molecules (albumin-bound Evans blue) into the vessel
wall. The Evans blue staining selectively highlighted the elastic
laminae, allowing visualization of the general morphologic pat-
tern and breaks in the elastica and confirming and augmenting
the TEM observations. No deposition of Evans blue-albumin
was present in the elastica of the wild-type mice (Fig. 6A).
These findings confirm that lower than normal levels of
ascorbic acid are detrimental to the maintenance of the normal
architectural integrity of the large vessels in the mutant mice.
Discussion
Humans, as a consequence of the loss during evolution of the
enzyme, L-gulono-g-lactone oxidase, are not able to synthesize
ascorbic acid, a small water-soluble antioxidant. Mice lacking the
same enzyme, like humans, depend on dietary supplementation
of vitamin C for survival. Thus, the Gulo 2y2 mice with 0.02
mgyg of body weightyday of ascorbic acid intake have 10%
normal plasma ascorbic acid levels and do not live longer than
6 weeks.
In humans, the Sheffield study carried out on healthy volun-
teers showed that the minimum protective dose of vitamin C
defined by the absence of clinical scurvy is 10 mgyday (20). This
result contributed importantly to the currently recommended
daily dose of 60 mgyday (0.001 mgyg of body weightyday) for
humans. Recent studies by Levine et al. (21) have shown,
however, that this daily dose maintains plasma ascorbic acid
levels in healthy male volunteers at subsaturation levels of about
25 mM; they recommended an increase in vitamin C intake to
200 mgyday, which saturates plasma level at 70 mM (12 mgyml).
The requirement of more than 0.08 mgyg per day of vitamin C
to reach comparable plasma levels in the Gulo 2y2 mice is
probably in part caused by the species differences in metabolic
rates and in plasma levels of uric acid; about 5 mgydl in humans
(22) and 0.9 mgydl in mice (23). Urate serves as a primary radical
scavenger and probably helps to maintain plasma level of
ascorbic acid by inhibiting iron-catalyzed ascorbate oxidation.
These species differences also are reflected in our finding that
approximately 72% of the total antioxidative capacity in normal
mouse plasma is accounted for by ascorbic acid, whereas ascor-
bic acid accounts for only 0–24% of plasma antioxidant capacity
in healthy human nonsmokers, whereas uric acid contributes
35–65% (22).
Although we do not exclude the possibility that Gulo 2y2
animals may accumulate oxidative damage in tissues or cells
after a prolonged period with insufficient vitamin C, no elevation
of lipid peroxidation products measured by plasma or liver
malonaldehyde was detectable in homozygotes after 4 weeks of
removing vitamin C from the drinking water. This result is not
surprising, because these mice still have 35% normal levels of
plasma total antioxidative capacity. Whether differences in the
levels of other biomarkers can be detected (24) or whether the
mutant animals will respond differently from wild-type mice to
various stresses, such as severe inflammatory conditions, re-
mains to be determined.
Epidemiological studies have not been conclusive in linking
vitamin C to cardiovascular diseases in humans (25). For exam-
ple, the World Health OrganizationyMONICA (monitering of
trends and determinants in cardiovascular diseases) study
showed, on a group level, an association of low plasma vitamin
C levels with high cardiovascular mortality (26). On the other
hand, in the Health Professionals Follow-up Study, no associa-
tion could be established (27). In mice with plasma ascorbic acid
levels ranging from normal to subnormal levels, we find that
plasma ascorbic acid levels in mice are inversely correlated with
plasma cholesterol and positively with HDL cholesterol. Similar
relationships also have been seen in some, but not all, human
studies (26, 28). Although vitamin C deficiency in guinea pigs has
been reported to be associated with 20–40% lower levels of HDL
cholesterol (29), the contribution of the plasma ascorbic acid
levels to the variance in HDL cholesterol levels seen in our
experiments was 10%. This contribution, although small, is
significant. In addition, the vitamin C-deficient mice have an
increase in low density lipoprotein-size particles and a small
decrease in HDL, giving them less favorable lipoprotein profiles
for cardiovascular protection than wild-type mice. The mecha-
nisms that underlie the observed relationship between the levels
of ascorbic acid and lipoproteins in the plasma of mice have not
Fig. 6. Evans blue extravasation in the ascending aorta of (A) a wild-type
mouse and (B) a Gulo 2y2 mouse. Magnification: 3200. Image processing was
used to subtract green autofluorescence, and the brighter area in this black
and white figure corresponds to the red fluorescence of Evans blue.











been determined, but a reduction in 7-a-hydroxylase activity has
been demonstrated in vitamin C-deficient guinea pigs (30–32).
Although further investigation is clearly needed, our results
re-emphasize the importance of proper vitamin C intake to
maintain a plasma lipoprotein profile that is associated with
reduced risk for coronary heart disease.
The most striking pathological finding in our current study is
the presence of abnormalities in the aortic walls of the vitamin
C-deficient mice. The simplest explanation of this pathology is
that the fragmentation of elastic lamina is caused by defects in
the crosslinking of collagen and elastin because of the need for
vitamin C to generate hydroxylysine and hydroxyproline. Sup-
port for this explanation is provided by the observations of
similar fragmentation of elastic fibers in mice with the Blotchy
allele at the X-linked Mottled locus (33). The Mottled locus codes
for a copper-transporting ATPase, which is necessary for lysyl
oxidase activity to crosslink collagen and elastin (34). Similar
aortic wall changes also have been seen in young rats treated with
b-aminopropionitrile, an inhibitor of lysyl oxidase (35, 36).
However, although the aortic wall abnormalities in Blotchy mice
progress to gross dilatation, aneurysm, and aortic rupture, the
abnormalities seen in our vitamin C-deficient mice appear to be
more subtle. The lesions in the aortic arch of vitamin C-deficient
mice are longitudinal and most frequently are seen near the
takeoff of the carotid where the blood flow related shear-stress
is high. We did not find platelets, fibrin, or other blood cells in
the areas with endothelial alteration. But there is a marked
increase in the extravasation of macromolecules into the aortic
wall in these areas as evidenced by the distribution of Evans blue
in the vitamin C-deficient mice.
In conclusion, we have generated mice lacking L-gulono-g-
lactone oxidase, a key enzyme for ascorbic acid synthesis. The
mutant mice, like humans, entirely depend on dietary vitamin C,
and they show changes indicating that the integrity of their
vasculature is compromised. When combined with the batteries
of mutant mice generated in recent years, the Gulo 2y2 mutant
mouse should provide unique opportunities for exploring the
interactions between genetic determination and environmental
factors, such as oxidative stress, and the effects on these inter-
actions of different levels of vitamin C in the diet.
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